GastroenterologyNews.net

Gastroenterology Xagena

Xagena Mappa
Medical Meeting
Farmaexplorer.it
Onco News

Active inflammatory bowel disease ( IBD ) adversely affects pregnancy outcomes. Little is known about the risk of relapse after stopping anti–tumor necrosis factor ( anti-TNF ) treatment during pregna ...


Whether statin type influences hepatocellular carcinoma ( HCC ) incidence or mortality in chronic hepatitis B or C virus infection is unknown. The objective of study was to assess the relationship ...


Functional dyspepsia is typically treated with serotonin receptor ( 5-HT ) agonists such as Cisapride, Mosapride, Tegaserod and Tandospirone citrate. However, there are conflicting efficacy data, po ...


Adults with severe obesity had greater initial and sustained weight loss with gastric bypass surgery than either sleeve gastrectomy or adjustable gastric banding, according to a new study published in ...


The increased risk of cancer persists into adulthood, and has not fallen since the introduction of modern drug therapies for inflammatory bowel disease. However, the researchers stress that absolute ...


For the first time, transplanting gut bacteria from healthy donors was used to successfully treat patients suffering from severe colitis caused by treatment with immune checkpoint inhibitors ( ICIs ). ...


The three-drug combination of Encorafenib ( Braftovi ), Binimetinib ( Mektovi ) and Cetuximab ( Erbitux ) has significantly improved overall survival ( OS ) in patients with BRAF-mutated metastatic c ...


The incidence and short-term outcome of anaemia in inflammatory bowel disease ( IBD ) are largely unknown. A study has attempted to determine the incidence, prevalence and clinical outcome of anae ...


An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet. Findings of the first phase 2 study of a biologic i ...


Inflammatory bowel disease [ IBD ] is associated with a 1.5- to 3-fold increased risk of venous thromboembolism [ VTE ] events. Researchers have determined the risk of venous thromboembolism in in ...


Tofacitinib ( Xeljanz ) is an oral, small molecule Janus kinase [ JAK ] inhibitor that is being investigated for ulcerative colitis [ UC ]. Researchers have evaluated health-related quality of life ...


Population-based prospective cohort studies investigating fibre intake and development of inflammatory bowel disease are lacking. Researchers have investigated the association between fibre intake ...


In phase 3 studies of Ustekinumab ( Stelara ), a fully human monoclonal IL-12/23p40 antibody approved for moderate-to-severe Crohn's disease, patients entered a long-term extension after completing 8 ...


In pediatric Crohn's disease, fat mass improves over time with treatment, but lean mass deficits persist. This observational study of the associations of physical activity and dietary intake wi ...


Vitamin and iron deficiencies are common in patients with inflammatory bowel disease ( IBD ) as a result of chronic intestinal inflammation, increase in demand, or dietary restrictions. Researcher ...